Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol vs flecainide in idiopathic ventricular arrhythmias
2023-510362-26-00Phase 4Authorised
- Sponsor
- Instituto de Investigación Sanitaria de Santiago de Compostela
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in ventricular arrhythmia (VA) comparing Carvedilol with Flecainide (2 arms). Planned start Apr 2024; status: authorised.
02
Drugs
carvedilolflecainide
03
Conditions
ventricular arrhythmia (VA)
Beyond the preview
Go deeper on 2023-510362-26-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-510362-26-00.